We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session Item

Saturday
May 07
08:45 - 10:00
Auditorium 11
Soft tissue sarcoma: Brachytherapy and/or EBRT or IORT - Current evidence
Csaba Polgar, Hungary;
Vratislav Strnad, Germany
In this session prestigious speakers will discuss and define current evidence for the optimal local radio-oncological treatment strategy with or without surgery for soft tissue sarcoma - the current evidence for EBRT, brachytherapy and IORT alone or for IORT /brachytherapy as a boost in adult soft-tissue sarcomas of the extremity, trunk and retroperitoneal space. For all treatment approaches the technical and practical state of the art considerations and recommendations will be also presented.
Debate
Brachytherapy
08:47 - 09:07
Value of EBRT
Antonin Levy, France
SP-0030

Abstract

Value of EBRT
Authors:

Antonin Levy1, Cécile Le Péchoux1

1Gustave Roussy, Radiation Oncology, Villejuif, France

Show Affiliations
Abstract Text

Radiation therapy is a standard treatment for limbs soft tissue sarcomas. External-beam radiotherapy (EBRT) has been the most commonly used modality. Modern EBRT techniques such as conformal image-guided intensity modulated radiotherapy (IGRT/IMRT) could decrease the incidence of complications. Preoperative versus postoperative EBRT has been a controversial topic for years but the neoadjuvant schedule is henceforth gaining ground. Newer drug-EBRT combinations are also being prospectively assessed. EBRT must be personalized according to the histological subtype, the tumor site and the benefit/risk ratio, which is best appreciated by a multidisciplinary surgical and oncological team in a specialized center in the management of soft-tissue sarcomas.